ISIN | LU1159236337 |
---|---|
Valor Number | 29080967 |
Bloomberg Global ID | |
Fund Name | State Street Europe Screened Index Equity Fund I |
Fund Provider |
State Street Global Advisors
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the Fund is to track the performance of the Eurozone equity markets. |
Peculiarities |
Current Price * | 18.36 EUR | 16.04.2025 |
---|---|---|
Previous Price * | 18.39 EUR | 15.04.2025 |
52 Week High * | 20.31 EUR | 03.03.2025 |
52 Week Low * | 17.02 EUR | 09.04.2025 |
NAV * | 18.36 EUR | 16.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 693,975,093 | |
Unit/Share Assets *** | 432,363,753 | |
Trading Information SIX |
YTD Performance | +0.21% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
---|---|---|
YTD Performance (in CHF) | -1.18% |
31.12.2024 - 16.04.2025
31.12.2024 16.04.2025 |
1 month | -8.07% |
18.03.2025 - 16.04.2025
18.03.2025 16.04.2025 |
3 months | -2.20% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -2.11% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +3.87% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +13.81% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +20.20% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +74.38% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.53% | |
---|---|---|
Nestle SA | 2.43% | |
ASML Holding NV | 2.37% | |
Roche Holding AG | 2.12% | |
AstraZeneca PLC | 2.07% | |
Novo Nordisk AS Class B | 2.04% | |
Shell PLC | 2.04% | |
Novartis AG Registered Shares | 2.00% | |
HSBC Holdings PLC | 1.91% | |
Siemens AG | 1.59% | |
Last data update | 31.03.2025 |
TER *** | 0.25% |
---|---|
TER date *** | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.20% |
Ongoing Charges *** | 0.25% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |